Omada Health (NASDAQ:OMDA) CAO Sells $14,651.00 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 637 shares of Omada Health stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $23.00, for a total value of $14,651.00. Following the sale, the chief accounting officer directly owned 15,441 shares in the company, valued at approximately $355,143. The trade was a 3.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Craig Gracey also recently made the following trade(s):

• On Tuesday, June 30th, Craig Gracey sold 405 shares of Omada Health stock. The stock was sold at an average price of $22.00, for a total value of $8,910.00.
• On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $21.00, for a total value of $43,743.00.
• On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The shares were sold at an average price of $20.00, for a total value of $41,680.00.
• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $19.01, for a total value of $39,597.83.
• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total value of $37,494.00.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total value of $120,093.48.

Omada Health Stock Performance

Shares of OMDA stock opened at $22.39 on Friday. The company’s fifty day moving average price is $17.32 and its 200-day moving average price is $15.08. The stock has a market cap of $1.33 billion and a PE ratio of -82.93. Omada Health, Inc. has a 12 month low of $10.28 and a 12 month high of $26.92.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $78.05 million during the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. On average, sell-side analysts forecast that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on OMDA shares. Citigroup reiterated an “outperform” rating on shares of Omada Health in a research note on Friday, May 8th. Wall Street Zen raised Omada Health from a “hold” rating to a “buy” rating in a research report on Saturday, June 27th. Canaccord Genuity Group set a $24.00 price objective on shares of Omada Health in a research report on Friday, May 8th. JPMorgan Chase & Co. reduced their price objective on shares of Omada Health from $32.00 to $26.00 and set an “overweight” rating for the company in a research note on Thursday, March 12th. Finally, Morgan Stanley reiterated an “overweight” rating and set a $30.00 price target on shares of Omada Health in a report on Monday, June 22nd. Ten analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Omada Health currently has a consensus rating of “Moderate Buy” and an average price target of $22.91.

Hedge Funds Weigh In On Omada Health

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Quarry LP bought a new stake in shares of Omada Health in the fourth quarter worth approximately $29,000. TD Waterhouse Canada Inc. bought a new position in Omada Health during the fourth quarter valued at approximately $32,000. Raymond James Financial Inc. purchased a new stake in Omada Health in the second quarter worth approximately $32,000. Inlight Wealth Management LLC purchased a new stake in Omada Health in the fourth quarter worth approximately $45,000. Finally, Versant Capital Management Inc grew its position in Omada Health by 319.3% in the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock worth $66,000 after purchasing an additional 2,283 shares during the period.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.